paper-with-me

Papers

A streamlined, general approach for computing ligand binding free energies and its application to GPCR-bound cholesterol

2018-09-28

The theory of receptor-ligand binding equilibria has long been well-established in biochemistry, and was primarily constructed to describe dilute aqueous solutions. Accordingly, few computational approaches have been developed for making quantitative predictions of binding probabilities in environments other than dilute isotropic solution. Existing techniques, ranging from simple automated docking procedures to sophisticated thermodynamics-based methods, have been developed with soluble proteins in mind. Biologically and pharmacologically relevant protein-ligand interactions often occur in complex environments, including lamellar phases like membranes and crowded, non-dilute solutions. Here we revisit the theoretical bases of ligand binding equilibria, avoiding overly specific assumptions that are nearly always made when describing receptor-ligand binding. Building on this formalism, we extend the asymptotically exact Alchemical Free Energy Perturbation technique to quantifying occupancies of sites on proteins in a complex bulk, including phase-separated, anisotropic, or non-dilute solutions, using a thermodynamically consistent and easily generalized approach that resolves several ambiguities of current frameworks. To incorporate the complex bulk without overcomplicating the overall thermodynamic cycle, we simplify the common approach for ligand restraints by using a single distance-from-bound-configuration (DBC) ligand restraint during AFEP decoupling from protein. DBC restraints should be generalizable to binding modes of most small molecules, even those with strong orientational dependence. We apply this approach to compute the likelihood that membrane cholesterol binds to known crystallographic sites on 3 GPCRs at a range of concentrations. Non-ideality of cholesterol in a binary cholesterol:POPC bilayer is characterized and consistently incorporated into the interpretation.

📄 PDF Abstract BibTeX arXiv:1801.04901

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

Ligand-induced protein dynamics differences correlate with protein-ligand binding affinities: An unsupervised deep learning approach

2021-09-03 · Ikki Yasuda, Katsuhiro Endo, Eiji Yamamoto, Yoshinori Hirano 외

Prediction of protein-ligand binding affinity is a major goal in drug discovery. Generally, free energy gap is calculated between two states (e.g., ligand binding and unbinding). The energy gap implicitly includes the ef…

Dimensionality ReductionDrug Discovery

Combining Alchemical Transformation with Physical Pathway to Accurately Compute Absolute Binding Free Energy

2018-08-28

We present a new method that combines alchemical transformation with physical pathway to accurately and efficiently compute the absolute binding free energy of receptor-ligand complex. Currently, the double decoupling me…

Using the Fast Fourier Transform in Binding Free Energy Calculations

2017-07-27 · Trung Hai Nguyen, Huan-Xiang Zhou, David D. L. Minh

According to implicit ligand theory, the standard binding free energy is an exponential average of the binding potential of mean force (BPMF), an exponential average of the interaction energy between the ligand apo ensem…

Molecular Docking

Binding equilibrium and kinetics of membrane-anchored receptors and ligands in cell adhesion: insights from computational model systems and theory

2016-06-14

The adhesion of cell membranes is mediated by the binding of membrane-anchored receptor and ligand proteins. In this article, we review recent results from simulations and theory that lead to novel insights on how the bi…

General Binding Affinity Guidance for Diffusion Models in Structure-Based Drug Design

2024-06-24 · Yue Jian, Curtis Wu, Danny Reidenbach, Aditi S. Krishnapriyan

Structure-Based Drug Design (SBDD) focuses on generating valid ligands that strongly and specifically bind to a designated protein pocket. Several methods use machine learning for SBDD to generate these ligands in 3D spa…

BenchmarkingDrug Design